{"id":"NCT00194129","sponsor":"University Hospitals Cleveland Medical Center","briefTitle":"Lithium and Divalproex for the Treatment of Comorbid Rapid Cycling Bipolar Disorder and Substance Abuse Disorder","officialTitle":"A Randomized, Double Blind Comparison of Lithium Monotherapy Versus Lithium Plus Divalproex for the Outpatient Management of Hypomania/Mania in Patients With Rapid Cycling Bipolar Disorder Comorbid With Substance Abuse/Dependence","status":"COMPLETED","phase":"PHASE3","dates":{"start":"1997-11","primaryCompletion":"2006-09","completion":"2006-09","firstPosted":"2005-09-19","resultsPosted":"2013-12-23","lastUpdate":"2018-02-20"},"enrollment":31,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Bipolar Disorder"],"interventions":[{"type":"DRUG","name":"Lithium","otherNames":["Lithium Carbonate"]},{"type":"DRUG","name":"Divalproex","otherNames":["Valproic Acid","Depakote"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Lithium plus Divalproex","type":"EXPERIMENTAL"},{"label":"Lithium plus placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study will determine the efficacy and safety of combination therapy with divalproex and lithium for treating mania in people with rapid cycling bipolar disorder and a substance abuse disorder.","primaryOutcome":{"measure":"Time to Treatment for Emerging Symptoms of a Mood Relapse","timeFrame":"Up to 6 months","effectByArm":[{"arm":"Lithium Plus Divalproex","deltaMin":17.8,"sd":null},{"arm":"Lithium Plus Placebo","deltaMin":15.9,"sd":null}],"pValues":[]},"eligibility":{"minAge":"16 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":9},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["19192457","18588360"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":15},"commonTop":["Tremors","Polyuria/Polydipsia","Diarrhea","Weight Gain","Fatigue"]}}